Who makes Guna-Geriatrics?

Guna-Geriatrics is developed by Guna spa.

What development phase is Guna-Geriatrics in?

Guna-Geriatrics is FDA-approved (marketed).

What is the generic name of Guna-Geriatrics?

RINFABATE is the generic (nonproprietary) name of Guna-Geriatrics.

Last reviewed 2026-04-20 · How we verify

Guna-Geriatrics (RINFABATE)

Guna spa · FDA-approved active Quality 6/100

At a glance

Generic name	RINFABATE
Sponsor	Guna spa
Drug class	Adrenocorticotropic Hormone [EPC]
Therapeutic area	Nephrology
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants (PHASE2)
Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP) (PHASE2)
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Guna-Geriatrics CI brief — competitive landscape report
Guna-Geriatrics updates RSS · CI watch RSS
Guna spa portfolio CI